Zijun J. Zhen

651 East Dongfeng Road
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Efficacy comparisons of chemotherapy regimens with different intensities in high-risk pediatric hepatoblastoma

Efficacy comparisons of chemotherapy regimens with different intensities in high-risk pediatric hepatoblastoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: August 13, 2026

Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety.

Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety.

Journal: International journal of cancer

Published: February 11, 2026

Precision Medicine Program in Chinese Pediatric Patients With Sarcoma.

Precision Medicine Program in Chinese Pediatric Patients With Sarcoma.

Journal: JCO precision oncology

Published: January 14, 2026

Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastoma.

Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastoma.

Journal: NPJ precision oncology

Published: January 04, 2026

Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma.

Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma.

Journal: Frontiers in immunology

Published: November 07, 2025

Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study.

Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study.

Journal: Chinese clinical oncology

Published: October 13, 2025

Causal relationship between hypertension and cancer: a two‑sample bidirectional Mendelian randomization study.

Causal relationship between hypertension and cancer: a two‑sample bidirectional Mendelian randomization study.

Journal: Translational cancer research

Published: June 02, 2025

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China.

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China.

Journal: Frontiers in immunology

Published: April 09, 2025

Pediatric NUT carcinoma: a patient series and literature review.

Pediatric NUT carcinoma: a patient series and literature review.

Journal: BMC pediatrics

Published: March 31, 2025

Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial.

Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial.

Journal: EClinicalMedicine

Published: March 05, 2025

Impact of tumor lysis syndrome on the prognosis of pediatric mature B-cell lymphoma

Impact of tumor lysis syndrome on the prognosis of pediatric mature B-cell lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 07, 2025

Prognostic Value of Peripheral Blood Lymphocyte Subsets in Children and Adolescents With High-Grade Mature B-Cell Non-Hodgkin Lymphoma: A Real-World Outcomes Study.

Prognostic Value of Peripheral Blood Lymphocyte Subsets in Children and Adolescents With High-Grade Mature B-Cell Non-Hodgkin Lymphoma: A Real-World Outcomes Study.

Journal: Pediatric blood & cancer

Published: November 05, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026